Li Yaqiong | 2nd Department Of Pathology Wakayama Medical University

スポンサーリンク

概要

• LI Yaqiongの詳細を見る
• 同名の論文著者
• 2nd Department Of Pathology Wakayama Medical Universityの論文著者

関連著者

• Matsuoka Hiroshi

  Department of Cardiology, Ehime Prefectural Imabari Hospital

• NAKAMINE Hirokazu

  Division of Pathology and Immunology, Kansai University for Health Science

• NAKAKUMA Hideki

  Department of Hematology/Oncology, Wakayama Medical University

• Nakamine Hirokazu

  Division Of Pathology And Immunology Kansai University For Health Science

• Nakamine Hirokazu

  Division Of Pathology And Immunology Kansai University Of Health Sciences

• Miyanishi Setsuko

  Tenri Institute Of Medical Research

• Nakakuma Hideki

  Department Of Hematology And Oncology Wakayama Medical University

• Li Yaqiong

  2nd Department Of Pathology Wakayama Medical University

• Sonoki Takashi

  Department Of Hematology And Oncology Wakayama Medical University

• Sonoki T

  Hematology/oncology Wakayama Medical University

• HANAOKA Nobuyoshi

  Department of Hematology/Oncology, Wakayama Medical University

• MORI Ichiro

  2nd Department of Pathology, Wakayama Medical University

• Matsuoka Hiroshi

  Department Of Hematology And Oncology Wakayama Medical University

• Matsuoka Hiroshi

  Department Of Applied Chemistry Faculty Of Science & Technology Keio University

• Hanaoka Nobuyoshi

  Department Of Hematology/oncology Wakayama Medical University

• Mori Ichiro

  2nd Department Of Pathology Wakayama Medical University

• Matsuoka Hiroshi

  Department Of Applied Chemistry Faculty Of Engineering Osaka University

• Sonoki Takashi

  Department of Hematology & Oncology, Wakayama Medical University

• Nakakuma Hideki

  Department of Hematology & Oncology, Wakayama Medical University

もっと見る 閉じる

著作論文

• Establishment of a novel CD20 negative mature B-cell line, WILL2, from a CD20 positive diffuse large B-cell lymphoma patient treated with rituximab

スポンサーリンク